BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mummadi RR, Petersen JR, Xiao SY, Snyder N. Role of simple biomarkers in predicting fibrosis progression in HCV infection. World J Gastroenterol 2010; 16(45): 5710-5715 [PMID: 21128320 DOI: 10.3748/wjg.v16.i45.5710]
URL: https://www.wjgnet.com/1007-9327/full/v16/i45/5710.htm
Number Citing Articles
1
Carolina Rumbo, María Inés Martinez, Ana Cabanne, Julio Trentadue, Adriana Fernández, Gabriel Gondolesi. Utility of Aminotransferase/Platelet Ratio Index to Predict Liver Fibrosis in Intestinal Failure–Associated Liver Disease in Pediatric PatientsJournal of Parenteral and Enteral Nutrition 2017; 41(5): 884 doi: 10.1177/0148607115625779
2
N. Tamaki, M. Kurosaki, K. Tanaka, Y. Suzuki, Y. Hoshioka, T. Kato, Y. Yasui, T. Hosokawa, K. Ueda, K. Tsuchiya, H. Nakanishi, J. Itakura, Y. Asahina, N. Izumi. Noninvasive estimation of fibrosis progression overtime using the FIB-4 index in chronic hepatitis CJournal of Viral Hepatitis 2013; 20(1): 72 doi: 10.1111/j.1365-2893.2012.01635.x
3
Agnieszka Bakula, Maciej Dadalski. Biomarkers in Liver DiseaseBiomarkers in Disease: Methods, Discoveries and Applications 2015; : 1 doi: 10.1007/978-94-007-7742-2_2-1
4
Sohan Lal Solanki, Jasmeen Kaur, Amit M. Gupta, Shraddha Patkar, Riddhi Joshi, Reshma P. Ambulkar, Akshay Patil, Mahesh Goel. Cancer related nutritional and inflammatory markers as predictive parameters of immediate postoperative complications and long-term survival after hepatectomiesSurgical Oncology 2021; 37: 101526 doi: 10.1016/j.suronc.2021.101526
5
Monica A. Konerman, Yiwei Zhang, Ji Zhu, Peter D.R. Higgins, Anna S.F. Lok, Akbar K. Waljee. Improvement of predictive models of risk of disease progression in chronic hepatitis C by incorporating longitudinal dataHepatology 2015; 61(6): 1832 doi: 10.1002/hep.27750
6
Chia-Chi Wang, Chen-Hua Liu, Chih-Lin Lin, Pin-Chao Wang, Tai-Chung Tseng, Hans Hsienhong Lin, Jia-Horng Kao. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patientsJournal of the Formosan Medical Association 2015; 114(10): 923 doi: 10.1016/j.jfma.2015.07.004
7
M. A. Konerman, S. Yapali, A. S. Lok. Systematic review: identifying patients with chronic hepatitis C in need of early treatment and intensive monitoring - predictors and predictive models of disease progressionAlimentary Pharmacology & Therapeutics 2014; 40(8): 863 doi: 10.1111/apt.12921
8
Jacinta A. Holmes, Alexander J. Thompson, Leon A. Adams. Biomarkers of Fibrosis and Fibrosis Progression in Chronic Hepatitis CCurrent Hepatitis Reports 2012; 11(4): 231 doi: 10.1007/s11901-012-0148-0
9
S. D. Holmberg, M. Lu, L. B. Rupp, L. E. Lamerato, A. C. Moorman, V. Vijayadeva, J. A. Boscarino, E. M. Henkle, S. C. Gordon, S. D. Holmberg, E. H. Teshale, P. R. Spradling, A. C. Moorman, S. C. Gordon, D. R. Nerenz, M. Lu, L. Lamerato, L. B. Rupp, N. Akkerman, N. J. Oja-Tebbe, C. M. Cogan, D. Larkin, J. A. Boscarino, Z. S. Daar, R. E. Smith, P. J. Curry, B. D. Geise, J. B. Leader, C. C. Nakasato, V. Vijayadeva, K. E. Sylva, J. V. Parker, M. M. Schmidt, E. M. Henkle, T. L. Dodge, E. M. Keast, L. Drew. Noninvasive Serum Fibrosis Markers for Screening and Staging Chronic Hepatitis C Virus Patients in a Large US CohortClinical Infectious Diseases 2013; 57(2): 240 doi: 10.1093/cid/cit245
10
Peter Ferenci, Rodrigo Aires, Kimberly L. Beavers, Manuela Curescu, Paulo R. Abrão Ferreira, Michael Gschwantler, Stefan Ion, Dominique Larrey, Mojca Maticic, Massimo Puoti, János Schuller, Istvan Tornai, Anna Tusnádi, Diethelm Messinger, Fernando Tatsch, Andrzej Horban. Predictive value of FIB-4 and APRI versus METAVIR on sustained virologic response in genotype 1 hepatitis C patientsHepatology International 2014; 8(1): 83 doi: 10.1007/s12072-013-9484-6
11
Yuemin Nan, Xuemin Niu, Rongqi Wang, Suxian Zhao, Na Fu, Jinghua Du, Yang Wang, Baoyu Wang, Yuguo Zhang. microRNA‑1273g‑3p is a useful non‑invasive test for the prediction of liver fibrosis in patients with chronic hepatitis CExperimental and Therapeutic Medicine 2018;  doi: 10.3892/etm.2018.7114
12
Xing-Xi Gao, Da-Hua Shi, Yun-Xi Chen, Jiang-Tao Cui, Yu-Rong Wang, Chun-Ping Jiang, Jun-Hua Wu. The therapeutic effects of tectorigenin on chemically induced liver fibrosis in rats and an associated metabonomic investigationArchives of Pharmacal Research 2012; 35(8): 1479 doi: 10.1007/s12272-012-0819-y
13
Kian Bichoupan, Valerie Martel-Laferriere, David Sachs, Michel Ng, Emily A. Schonfeld, Alexis Pappas, James Crismale, Alicia Stivala, Viktoriya Khaitova, Donald Gardenier, Michael Linderman, Ponni V. Perumalswami, Thomas D. Schiano, Joseph A. Odin, Lawrence Liu, Alan J. Moskowitz, Douglas T. Dieterich, Andrea D. Branch. Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological responseHepatology 2014; 60(4): 1187 doi: 10.1002/hep.27340
14
Abdel-Rahman Zekri, Mohamed El-Kassas, Yasmin Saad, Abeer Bahnassy, Hany Khatab Sameh Seif El-Din, Samar K. Darweesh, Hanan Abdel Hafez, Gamal Esmat. Caspase recruitment domains. New potential markers for diagnosis of hepatocellular carcinoma associated with HCV in Egyptian patientsAnnals of Hepatology 2013; 12(5): 774 doi: 10.1016/S1665-2681(19)31319-5
15
Agnieszka Bakula, Maciej Dadalski. Biomarkers in Liver DiseaseBiomarkers in Disease: Methods, Discoveries and Applications 2017; : 305 doi: 10.1007/978-94-007-7675-3_2
16
Konstantinos C. Fragkos, María Claudia Picasso Bouroncle, Shankar Kumar, Lucy Caselton, Alex Menys, Alan Bainbridge, Stuart A. Taylor, Francisco Torrealdea, Tomoko Kumagai, Simona Di Caro, Farooq Rahman, Jane Macnaughtan, Manil D. Chouhan, Shameer Mehta. Serum Scoring and Quantitative Magnetic Resonance Imaging in Intestinal Failure-Associated Liver Disease: A Feasibility StudyNutrients 2020; 12(7): 2151 doi: 10.3390/nu12072151